Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rothenberg

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Annals of the New York Academy of Sciences|February 24, 2001
p53 and p21 are major cellular determinants for DNA topoisomerase I-mediated radiation sensitization in mammalian cellsA Y Chen, P B Scruggs, L Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
Diabetes|June 1, 1996
Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cellsM C Harbeck, D C Louie, J Howland, et al.
The American Journal of Cardiology|February 15, 1987
Infected acute myocardial infarct with rupture in systemic lupus erythematosusM J Cunningham, P L Rothenberg, S Schatten, et al.
International Journal of Oncology|September 15, 1998
Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cellsY Gazitt, M L Rothenberg, S G Hilsenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!David S Alberts, Maurie Markman, Deborah Armstrong, et al.
Bulletin of the Medical Library Association|October 1, 1970
Certification reformA M Rees, R G Cheshier, T G Morris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology GroupD S Alberts, C Jiang, P Y Liu, et al.
The Journal of Biological Chemistry|May 5, 1991
Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinaseP L Rothenberg, W S Lane, A Karasik, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?Edward V Nunes, Jami L Rothenberg, Maria A Sullivan, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Annals of the New York Academy of Sciences|February 24, 2001
p53 and p21 are major cellular determinants for DNA topoisomerase I-mediated radiation sensitization in mammalian cellsA Y Chen, P B Scruggs, L Geng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
Diabetes|June 1, 1996
Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cellsM C Harbeck, D C Louie, J Howland, et al.
The American Journal of Cardiology|February 15, 1987
Infected acute myocardial infarct with rupture in systemic lupus erythematosusM J Cunningham, P L Rothenberg, S Schatten, et al.
International Journal of Oncology|September 15, 1998
Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cellsY Gazitt, M L Rothenberg, S G Hilsenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!David S Alberts, Maurie Markman, Deborah Armstrong, et al.
Bulletin of the Medical Library Association|October 1, 1970
Certification reformA M Rees, R G Cheshier, T G Morris, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology GroupD S Alberts, C Jiang, P Y Liu, et al.
The Journal of Biological Chemistry|May 5, 1991
Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinaseP L Rothenberg, W S Lane, A Karasik, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?Edward V Nunes, Jami L Rothenberg, Maria A Sullivan, et al.
Pageof 17